The Claim
Six months of high-dose omega-3 supplementation (3.6 g/day EPA+DHA) significantly reduces plasma prostaglandin E2 levels by approximately 20–30% in heavy smokers with elevated inflammation, and this reduction correlates inversely with red blood cell membrane DHA levels but not with EPA levels.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In heavy smokers with high inflammation, taking 3.6 grams of omega-3 fatty acids daily for six months lowers plasma prostaglandin E2 levels by 20–30%. The degree of reduction is related to the amount of DHA in red blood cell membranes, but not to EPA levels.
See the scientific wording
Six months of high-dose omega-3 supplementation (3.6 g/day EPA+DHA) significantly reduces plasma prostaglandin E2 levels by approximately 20–30% in heavy smokers with elevated inflammation, with the effect correlating inversely with red blood cell membrane DHA levels but not EPA levels.
DHA from omega-3 supplements enters cell membranes and pushes out a fatty acid called arachidonic acid. With less arachidonic acid available, the enzyme that makes inflammatory prostaglandin E2 has less material to work with, so less of it is produced. The more DHA in the membrane, the less prostaglandin E2 is made.
What the research says
1 studyTaking 3.6 grams of omega-3 fish oil daily for six months lowered a key inflammatory chemical in the blood of heavy smokers, and this drop was tied to higher levels of DHA in their blood cells — not EPA. The study proves this exact effect happened.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.